Evidence map›Paper›PMID 33658921›Full record

ArticleFrontiers in pharmacology2020

Corrigendum: β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-Pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial-Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling.

Zhang-Qi Cao, Xue-Xi Wang, Li Lu, Jing-Wen Xu, Xiao-Bin Li, Guang-Ru Zhang, Zhan-Jun Ma, An-Chen Shi, Yan Wang, Yu-Jun Song

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. 3,3'-Di-O-methylellagic Acid Isolated fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Exploring the molecular mechanism of Xiao Ji (Asian biomedicine : research, reviews and news · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Zhang-Qi CaoSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Xue-Xi WangSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Li LuSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Jing-Wen XuSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Xiao-Bin LiSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Guang-Ru ZhangQinghai Hospital of Traditional Chinese Medicine, Xining, China.
Zhan-Jun MaThe Second Clinical School, Lanzhou University, Lanzhou, China.
An-Chen ShiThe Second Clinical School, Lanzhou University, Lanzhou, China.
Yan WangSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Yu-Jun SongSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fphar.2018.01525.].

Indexed as

AKTapoptosisEMTgemcitabineGSK-3βpancreatic cancerβ-sitosterol

Identifiers

PMID33658921
PMCPMC7919186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.